ANROVSENHA• 12 Months (Normalized)
ANRO vs ENHA (Alto Neuroscience Inc. vs Enhanced Group Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $24.8
+462.36%
Alto Neuroscience Inc.
Normalized Baseline0.00%
ENHA Performance $1.47
-84.85%
Enhanced Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+547.21 pts
ANRO outperforming by 547.21 percentage points
ANROENHA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO ENHA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ANRO Price | ANRO Gain (%) | ENHA Price | ENHA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $24.80 | +462.36% | $1.47 | -84.85% | +547.21% |
| Sep 30, 2026 | $25.88 | +486.85% | $- | - | |
| Sep 29, 2026 | $26.58 | +502.72% | $- | - | |
| Sep 28, 2026 | $26.66 | +504.54% | $1.56 | -83.97% | +588.51% |
| Sep 25, 2026 | $26.49 | +500.68% | $1.44 | -85.15% | +585.83% |
| Sep 24, 2026 | $27.18 | +516.33% | $1.47 | -84.85% | +601.18% |
| Sep 23, 2026 | $27.50 | +523.58% | $1.40 | -85.57% | +609.15% |
| Sep 22, 2026 | $30.78 | +597.96% | $1.49 | -84.64% | +682.60% |
| Sep 21, 2026 | $30.63 | +594.56% | $1.43 | -85.26% | +679.82% |
| Sep 18, 2026 | $30.27 | +586.39% | $1.44 | -85.15% | +671.54% |
| Sep 17, 2026 | $30.98 | +602.49% | $1.46 | -84.95% | +687.44% |
| Sep 16, 2026 | $30.00 | +580.27% | $1.43 | -85.26% | +665.53% |
| Sep 15, 2026 | $30.25 | +585.94% | $1.53 | -84.23% | +670.17% |
| Sep 14, 2026 | $31.68 | +618.37% | $1.58 | -83.71% | +702.08% |
| Sep 11, 2026 | $32.00 | +625.62% | $1.56 | -83.92% | +709.54% |
Page 1 of 17